ARTICLE | Company News

Gilead, Roche, U.S. Department of Health and Human Services infectious news

September 26, 2005 7:00 AM UTC

ROCZ is in talks with HHS for an additional 20 million treatment courses of influenza drug Tamiflu oseltamivir for the 2005-06 flu season. HHS already has enough of the oral neuraminidase inhibitor ...